Stock listing
PDSB Stock Price, News, Filings & Events — Pds Biotechnology Corporation
Selected listing: PDSB · NASDAQ · USD · US
This page tracks Pds Biotechnology Corporation's PDSB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PDSB:NASDAQ. PDSB:NASDAQ is the stock-level entry point for investors researching Pds Biotechnology Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. PDS Biotechnology Corporation, trading under the ticker PDSB, is a public company based in the United States with a market capitalization of approximately $38.1 million. The company focuses on developing innovative therapies for cancer and infectious diseases. PDS Biotechnology aims to advance its proprietary technology to improve patient outcomes in the healthcare sector.
- Ticker
- PDSB:NASDAQ
- Asset type
- Stock
- Market cap
- $11.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Pds Biotechnology Corporation PDSB:NASDAQ stock context
This page tracks Pds Biotechnology Corporation's PDSB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PDSB:NASDAQ. PDSB:NASDAQ is the stock-level entry point for investors researching Pds Biotechnology Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. PDS Biotechnology Corporation, trading under the ticker PDSB, is a public company based in the United States with a market capitalization of approximately $38.1 million. The company focuses on developing innovative therapies for cancer and infectious diseases. PDS Biotechnology aims to advance its proprietary technology to improve patient outcomes in the healthcare sector.
Latest news from Pds Biotechnology Corporation
PDS Biotech Reports Second Quarter 2026 Financial Results
August 13, 2026
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
August 11, 2026
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
May 13, 2026
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
May 6, 2026
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal ...
April 15, 2026
Pds Biotechnology Corporation earnings calls
PDS Biotechnology Corporation (PDSB) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
PDS Biotechnology Corporation (PDSB) Q4 2025 Earnings Call
March 30, 2026 · Replay with transcript and chapters
PDS Biotechnology Corporation (PDSB) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
PDS Biotechnology Corporation (PDSB) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
PDS Biotechnology Corporation (PDSB) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call
March 27, 2025 · Replay with transcript and chapters
Research Pds Biotechnology Corporation
Pds Biotechnology Corporation investor report
Review AI stock analysis and investor report context for PDSB:NASDAQ.
Pds Biotechnology Corporation company profile
View the public company page for Pds Biotechnology Corporation on 6ix.
Pds Biotechnology Corporation news
Read company news and market updates connected to Pds Biotechnology Corporation.
Pds Biotechnology Corporation investor events
Find investor webinars, events, and replay context for Pds Biotechnology Corporation.
Alternate listings
A2PF3F:LSX
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:GETTEX
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
A2PF3F:LS
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:TRADEGATE
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
PDSB:BOATS
US · USD
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:FWB
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:DUS
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:HAM
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:MUN
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.
EU6:SWB
DE · EUR
Alternate listing for Pds Biotechnology Corporation; the primary context on this page is PDSB:NASDAQ.